Limin Group Co Ltd

Limin Group maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.36, indicating a moderate reliance on debt financing. The company's liquidity position is characterized as medium risk, with a current ratio of 1.21, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited buffer. Free cash flow of 674.36 million CNY supports operational flexibility, though net cash is negative after subtracting total debt, signaling potential refinancing needs. Profitability metrics show a return on equity (ROE) of 12.11% and a return on assets (ROA) of 7.28%, both of which are in line with the industry's preferred metrics for agricultural chemicals. The gross profit margin of 25.52% (1155.71 million CNY on 4526.96 million CNY revenue) is a key indicator of the company's pricing power and cost control. However, the operating margin of 12.88% (583.21 million CNY) suggests that operating expenses are consuming a significant portion of gross profit. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification beyond China. This concentration increases exposure to domestic economic and regulatory shifts, particularly in the agricultural sector, which is a primary market for its products. Looking ahead, Limin Group is projected to see a modest increase in revenue, with a year-over-year growth rate of approximately 3.5% in the current fiscal year and a 4.2% growth in the next fiscal year. These projections are supported by stable demand for agricultural chemicals in China and a controlled cost structure. However, the company's capital expenditure is negative at -86.86 million CNY, indicating a reduction in investment in new projects or capacity expansion. Risk factors include medium liquidity risk and a potential need for refinancing due to negative net cash after debt. The company's dilution risk is assessed as low, with no significant dilution expected in the near term. However, the risk assessment notes that the company's liquidity position could deteriorate if operating cash flow does not improve or if debt obligations increase. Recent events include a stable analyst outlook, with one "buy" recommendation and no "strong buy" or "sell" ratings. The mean EPS estimate for the upcoming period is 1.24 CNY, slightly above the last actual EPS of 1.17 CNY, indicating a modest earnings growth expectation. No major regulatory or operational events have been disclosed in the latest filings or transcripts.